Molecular Formula | C15H25ClN2O2 |
Molar Mass | 300.82 |
Density | 1.1279 (rough estimate) |
Melting Point | 149°C |
Boling Point | 389.4°C at 760 mmHg |
Flash Point | 189.3°C |
Water Solubility | Soluble in water at 50mg/ml |
Solubility | alcohol: solublesoluble 40 parts of solvent |
Vapor Presure | 2.87E-06mmHg at 25°C |
Appearance | neat |
Color | White to Almost white |
Merck | 14,9188 |
pKa | 8.39(at 25℃) |
Storage Condition | 2-8°C |
Refractive Index | 1.5200 (estimate) |
Use | Used as a local anesthetic |
Hazard Symbols | T - Toxic |
Risk Codes | R25 - Toxic if swallowed R36 - Irritating to the eyes R43 - May cause sensitization by skin contact R42/43 - May cause sensitization by inhalation and skin contact. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36/37 - Wear suitable protective clothing and gloves. S45 - In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.) S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection. S22 - Do not breathe dust. S53 - Avoid exposure - obtain special instructions before use. |
UN IDs | 2811 |
WGK Germany | 3 |
RTECS | DG4900000 |
HS Code | 29224999 |
Hazard Class | 6.1 |
Packing Group | III |
Toxicity | LD50 i.p. in mice: 70 mg/kg (Dawes); also reported as LD50 in female mice (mg/kg): 13 i.v.; 35 s.c. (Bopp) |
This product is 4-(butylamino) benzoic acid -2-(dimethylamino) ethyl ester hydrochloride. The content of C15H24N202 • HCl shall not be less than 99.0% calculated on a dry basis.
The melting point of this product (General rule 0612 first method) is 147~150°C.
take this product, add water to dissolve and dilute the solution containing about 10 mg per lml, and determine it according to law (General 0631). The pH value should be 4.5~6.5.
take l.Og of this product, Add 10ml of water to dissolve, the solution should be clear and colorless; If it is turbid, it should not be more concentrated compared with No. 1 turbidity standard solution (General rule 0902 first method).
take this product, precision weighing, adding water to dissolve and quantitatively dilute to make a solution containing 50mg per lml, as a test solution; Take the other butyl amino benzoic acid reference, precision weighing, methanol was added to dissolve and quantitatively diluted to prepare 0.10 mg solution, as a control solution. According to the thin layer chromatography (General 0502) test, absorb the above two solutions each 5 u1, respectively, on the same silica gel GF 254 thin layer plate, with chloroform-methanol-isopropylamine (98:7:2) for the development of the agent, expand, dry, set the UV light (254nm) under the inspection. If the test solution shows impurity spots, the color should not be deeper compared with the main spots of the reference solution.
take 0.50g of this product and check it according to law (General rule 0842). Compared with the orange-yellow 3 Standard Colorimetric solution (General rule 0901, first method), it shall not be deeper.
take this product, dry to constant weight at 105°C, weight loss shall not exceed 1.0% (General rule 0831).
l.Og of this product shall be taken for inspection according to law (General rule 0841), and the residual Tongtong shall not exceed 0.1%.
The residue left under the item of taking the ignition residue shall not contain more than 10 parts per million of heavy metal when examined by law (General Principles 0821, Law II).
take about 0.25g of this product, weigh precisely, add 50ml of ethanol, shake to dissolve, add 5ml of 0.01md/L hydrochloric acid solution, shake well, potentiometric titration (General 0701), with sodium hydroxide titration solution (0.1 mol/L) titration, the difference between the two burst point volumes as The titration volume. Each 1 ml of sodium hydroxide titration solution (0.1 mol/L) corresponds to 30.08mg of C15H24N202. Hc1.
local anesthetic.
sealed storage.
This product is a sterile freeze-dried product of tetracaine hydrochloride. Tetracaine hydrochloride (C15H24N202 • HC1) shall be present at 93.0% to 107.0% of the label load.
This product is a white loose mass or powder.
Take 10 bottles of this product, add water to dissolve, and quantitatively transfer to 250ml measuring flask, dilute with water to scale, shake, as a test solution; Take tetracaine hydrochloride control, precision weighing, dissolved in water and quantitative dilution to make a solution containing about 0.2mg per 1 ml, as a reference solution. Take 3ml of test solution and 3ml of reference solution respectively, put them into l-200 measuring flask, and add 5ml of hydrochloric acid solution () and phosphate buffer solution (pH 6.0). (Take 20g of Dipotassium hydrogen phosphate and 80g of potassium dihydrogen phosphate, add water to dissolve and dilute to 1000ml, adjust the pH value to 6.0 with 6mol/L phosphoric acid solution or 10 mol/L potassium hydroxide solution) 10ml, dilute to the scale with water, shake well, according to UV-visible spectrophotometry (General rule 0401), the absorbance was measured at the wavelength of 310mn, the content of each bottle was calculated, and the average content was obtained.
Same as tetracaine hydrochloride.
50mg
light shielding, closed storage.